VisionPoint Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.29M Buy
10,039
+1,220
+14% +$143K 0.21% 112
2026
Q1
$1.06M Buy
8,819
+324
+4% +$37.4K 0.2% 115
2025
Q4
$894K Buy
8,495
+5,221
+159% +$490K 0.17% 123
2025
Q3
$275K Buy
3,274
+219
+7% +$18K 0.05% 310
2025
Q2
$242K Buy
+3,055
New +$243K 0.05% 310
2025
Q1
Sell
-2,843
Closed -$282K 270
2024
Q4
$282K Sell
2,843
-2,065
-42% -$213K 0.1% 151
2024
Q3
$557K Buy
4,908
+443
+10% +$52.6K 0.19% 105
2024
Q2
$553K Sell
4,465
-7,579
-63% -$976K 0.2% 103
2024
Q1
$1.59M Sell
12,044
-7,154
-37% -$882K 0.57% 45
2023
Q4
$2.09M Buy
19,198
+717
+4% +$74.4K 0.77% 34
2023
Q3
$1.9M Buy
18,481
+3,049
+20% +$329K 0.82% 30
2023
Q2
$1.78M Sell
15,432
-9,154
-37% -$1.04M 0.73% 41
2023
Q1
$2.89M Sell
24,586
-24,450
-50% -$2.64M 1.27% 18
2022
Q4
$5.37M Sell
49,036
-6,843
-12% -$699K 2.22% 12
2022
Q3
$4.81M Sell
55,879
-2,697
-5% -$241K 2.31% 16
2022
Q2
$5.21M Sell
58,576
-3,176
-5% -$282K 2.06% 17
2022
Q1
$5.61M Buy
61,752
+241
+0.4% +$19K 2.6% 15
2021
Q4
$4.83M Buy
61,511
+2,656
+5% +$212K 2.11% 18
2021
Q3
$4.8M Buy
+58,855
New +$4.48M 2.14% 17
2021
Q2
Sell
-3,372
Closed -$248K 105
2021
Q1
$248K Sell
3,372
-3,550
-51% -$262K 0.12% 104
2020
Q4
$540K Sell
6,922
-24,683
-78% -$1.89M 0.27% 76
2020
Q3
$2.5M Sell
31,605
-8,217
-21% -$644K 1.08% 15
2020
Q2
$2.93M Buy
39,822
+3,845
+11% +$289K 1.19% 19
2020
Q1
$2.64M Buy
+35,977
New +$2.83M 1.24% 16

Other funds holding MRK

VisionPoint Advisory Group's MRK Position: Q2 2026 in Review

VisionPoint Advisory Group increased its Merck (MRK) stake by 14% in Q2 2026, buying an estimated $143K and bringing the position to 10,039 shares worth $1.29M. The position accounts for 0.21% of the portfolio, ranked #112.

VisionPoint Advisory Group first reported a position in MRK in Q1 2020 and has held it in 24 quarters since. The position peaked at $5.61M in Q1 2022. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • VisionPoint Advisory Group held 10,039 shares of Merck worth $1.29M as of Q2 2026.
  • VisionPoint Advisory Group bought 1,220 Merck shares in Q2 2026, an estimated $143K.
  • Merck made up 0.21% of VisionPoint Advisory Group's portfolio in Q2 2026, its #112 holding.
  • VisionPoint Advisory Group first reported a position in Merck in Q1 2020 and has held it in 24 quarters since.
  • VisionPoint Advisory Group's Merck position peaked at $5.61M in Q1 2022.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on VisionPoint Advisory Group's 13F filing for Q2 2026, filed 7 Jul 2026.